Is There Something I Need to Be Concerned About?

The ultimate test of tolerability is if some one has to discontinue because of an adverse event. It took a hundred people to be randomized to one of these v metu inhibitors versus vasibo, before expecting to encounter one patient who had to stop because of an adverse event. So that's hardly any one. When youwhen you look at the number needed to treat for robust response,. And it's a five for every five who are andomized, either one versus placibo, before you encounter one additional person with robust response. That would be 20, 20. You're 20 times more likely to encounter robust response than have to stop the drug because of a adverse event.